Advertisement

Pfizer'S

Latest Stories

The Pfizer name is displayed at the company's headquarters, Feb. 5, 2021, in New York. (AP Photo/Mark Lennihan, File)

Kansas sues Pfizer over purportedly false claims its COVID-19 shot was ‘safe and effective’

By Alex Swoyer - The Washington Times

Conservative activist Edward Blum speaks at a news conference in Washington, June 29, 2023. Blum is citing Section 1981 of the Civil Rights Act of 1866 to go after a venture capital fund called Fearless Fund, which invests in businesses owned by women of color. (AP Photo/Jose Luis Magana)

DEI opponents are using a 1866 Civil Rights law to challenge equity policies in the workplace

By Anne D'Innocenzio and Alexandra Olson - Associated Press

Doses of the anti-viral drug Paxlovid are displayed in New York, on Monday, Aug. 1, 2022. Pfizer's COVID-19 pill may provide little benefit for younger adults, while still reducing the risk of hospitalization and death for higher-risk seniors, according to an Israeli study published Wednesday, Aug 24, 2022. (AP Photo/Stephanie Nano)

Once-free COVID-19 treatments to enter market with hefty price tag

By Amanda Seitz - Associated Press

Debris is scattered around the Pfizer facility on Wednesday, July 19, 2023, in Rocky Mount, N.C., after damage from severe weather. (Travis Long/The News & Observer via AP)

Tornado damage to Pfizer plant will probably create long-term shortages of some drugs hospitals need

By Tom Murphy - Associated Press

The anti-viral drug Paxlovid is displayed in New York, Monday, Aug. 1, 2022. Pfizer received full approval for the COVID-19 medication on Thursday, May 25, 2023, winning the U.S. Food and Drug Administration's full endorsement for a drug that has been the go-to treatment against the virus for more than two years. (AP Photo/Stephanie Nano, File)

COVID pill Paxlovid gets full FDA approval after more than a year of emergency use

By Matthew Perrone - Associated Press

This electron microscope image provided by the National Institutes of Health shows human respiratory syncytial virus (RSV) virions, colorized blue, and anti-RSV F protein/gold antibodies, colorized yellow, shedding from the surface of human lung cells. Advisers to the Food and Drug Administration on Thursday, May 18, 2023 debated a first-of-its-kind RSV vaccine to protect newborns by immunizing their moms late in pregnancy. (National Institute of Allergy and Infectious Diseases, NIH via AP)

FDA advisers back RSV vaccine for pregnant women that protects their newborns

By Lauran Neergaard - Associated Press

Deborah Sampson, left, a nurse at a University of Washington Medical Center clinic in Seattle, gives a Pfizer COVID-19 vaccine shot to a 20-month-old child, June 21, 2022, in Seattle. Pfizer is asking U.S. regulators to authorize its updated COVID-19 vaccine for children under age 5. The youngest tots already are supposed to get three extra-small doses of the original vaccine as their primary series. Pfizer and its partner BioNTech said Monday, Dec. 5, 2022 that if the Food and Drug Administration agrees, the updated vaccine would be used for the third shot. The FDA already has cleared COVID-19 vaccines tweaked to better target omicron as boosters for everyone 5 and older. (AP Photo/Ted S. Warren, file)

Pfizer asks FDA to clear updated COVID shot for kids under 5

By Lauran Neergaard - Associated Press

A man walks by Pfizer headquarters in New York on Friday, Feb. 5, 2021. (AP Photo/Mark Lennihan) **FILE**

Pfizer sued for excluding White, Asian candidates from fellowship

By Sean Salai - The Washington Times

This August 2022 photo provided by Pfizer shows vials of the company's updated COVID-19 vaccine during production in Kalamazoo, Mich. U.S. regulators have authorized updated COVID-19 boosters, the first to directly target today's most common omicron strain. The move on Wednesday, Aug. 13, 2022, by the Food and Drug Administration tweaks the recipe of shots made by Pfizer and rival Moderna that already have saved millions of lives. (Pfizer via AP)

CDC advisers weigh who needs updated COVID booster and when

By Lauran Neergaard - Associated Press

A boy receives a dose of China's Sinovac COVID-19 coronavirus vaccine at a community vaccination center in Hong Kong on Feb. 25, 2022. U.S. government advisers met Wednesday, June 15, 2022 to decide whether to endorse COVID-19 shots for babies, toddlers and preschoolers, moving the nation closer to vaccinations for all ages. According to the World Health Organization, 12 countries are vaccinating kids under 5. (AP Photo/Kin Cheung, File)

FDA advisers weigh COVID-19 shots for babies, young children

By Lindsey Tanner and Mike Stobbe - Associated Press

In this photo provided by Pfizer, a lab technician visually inspects COVID-19 Paxlovid tablet samples in Freiburg, Germany in December 2021. As more doctors prescribe Pfizer's powerful COVID-19 pill, new questions are emerging about its performance, including why a small number of patients appear to relapse after taking the drug. (Pfizer via AP, File)

Cases of COVID returning pose questions for Pfizer pill

By Matthew Perrone - Associated Press

FILE - A nursing student administers a Moderna COVID-19 vaccine at a vaccination center at UNLV, in Las Vegas on April 26, 2021. The Food and Drug Administration on Friday, April 29, 2022, set tentative dates in June to publicly review COVID-19 vaccines for the youngest American children, typically the final step before authorizing the shots. (AP Photo/John Locher, File)

FDA sets June meetings on COVID vaccines for youngest kids

By Matthew Perrone - Associated Press

In this March 4, 2021 file photo, a vial of the Moderna COVID-19 vaccine rests on a table at a drive-up mass vaccination site in Puyallup, Wash., south of Seattle. Moderna’s COVID-19 vaccine brought in nearly $7 billion in the final quarter of 2021, and the drugmaker says it has signed purchase agreements for another $19 billion in sales this year. (AP Photo/Ted S. Warren, File)

Moderna seeks FDA authorization for 4th dose of COVID shot for all adults

By Zeke Miller - Associated Press

In this Thursday, July 15, 2021, file photo, Surgeon General Dr. Vivek Murthy speaks during the daily briefing at the White House in Washington. (AP Photo/Susan Walsh) ** FILE **

Surgeon general says FDA won’t cut corners in approving COVID-19 vaccine for young kids

By Tom Howell Jr. - The Washington Times

Nurse Lydia Holly prepares a child's COVID-19 vaccine dose, on Nov. 3, 2021, at Children's National Hospital in Washington. U.S. regulators are urging drugmaker Pfizer to apply for emergency authorization for a two-dose regimen of its COVID-19 vaccine for children ages 5 and under while awaiting data on a three-dose course, aiming to clear the way for the shots as soon as late February. (AP Photo/Carolyn Kaster, File)

Pfizer set to request emergency approval of COVID-19 vaccine for children younger than 5

By Tom Howell Jr. - The Washington Times

This image provided by Pfizer shows the company's COVID-19 Paxlovid pills. Pfizer's and Merck's COVID-19 pills that were supposed to be an important weapon against the pandemic in the U.S. are in short supply and have played little role in the fight against the omicron wave of infections. (Pfizer via AP, File)

COVID-19 pill rollout stymied by shortages as omicron rages

By Matthew Perrone - Associated Press

Use common sense to navigate COVID-19

THE WASHINGTON TIMES

Elizabeth Holmes, center, walks into federal court in San Jose, Calif., Monday, Nov. 22, 2021. Holmes is accused of duping elite financial backers, customers and patients into believing that her startup was about to revolutionize medicine. (AP Photo/Nic Coury)

Elizabeth Holmes denies deception at her criminal trial

By Michael Liedtke - Associated Press

A health care worker receives a Pfizer COVID-19 booster shot at Jackson Memorial Hospital Tuesday, Oct. 5, 2021, in Miami. (AP Photo/Lynne Sladky) ** FILE **

Pfizer’s booster request sets up a pivotal decision for FDA

By Tom Howell Jr. - The Washington Times

This October 2021 photo provided by Pfizer shows kid-size doses of its COVID-19 vaccine in Puurs, Belgium. The vaccine appear safe and nearly 91% effective at preventing symptomatic infections in 5- to 11-year-olds, according to study details released Friday, Oct. 22, as the U.S. considers opening vaccinations to that age group. (Pfizer via AP)

FDA panel recommends COVID-19 vaccine for ages 5-11

By Tom Howell Jr. - The Washington Times